**NCI Summer Curriculum in**

**Cancer Prevention**

**\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\***

**Principles and Practice of**

**Cancer Prevention and Control**

##### **Course**

# **July 7 through August 1, 2008**

**6001 Executive Boulevard**

**Conference Rooms C and D**

###### **Rockville, MD 20852**

**301-435-1465**

#### **Course Syllabus**

**2008**

### *U.S. Department of Health and Human Services*

*National Institutes of Health*

### *National Cancer Institute*

*Office of Preventive Oncology*

NCI Summer Curriculum in Cancer Prevention

Principles and Practice of Cancer Prevention and Control Course

Date: July 7 through August 1, 2008

Time: 8:30 a.m. to 10:00 a.m.

10:30 a.m. to 12:00 noon

1:00 p.m. to 2:30 p.m.

(Occasionally, lecture times will vary.)

Location: 6001 Executive Boulevard

> Conference Rooms C and D

Rockville, Maryland 20852

301-435-1465

Activity Director: Jonathan Wiest, PhD, Acting Director

Cancer Prevention Fellowship Program

Course presented by:

Office of Preventive Oncology Jonathan Wiest, PhD, Acting Director

National Cancer Institute Jackie A. Lavigne, PhD, MPH, Associate
Director

National Institutes of Health Trishna Dey, Program Specialist

EPS, Suite T-41 Blanca Bonilla, Program Assistant

6120 Executive Boulevard Ellen Jaffe, Secretary

Bethesda, Maryland 20892-7105 Jonelle C. Saunders, Summer Intern

Telephone: 301-496-8640

Fax: 301-480-2669

http://cancer.gov/prevention/pob

**Course Description**

This four-week summer course provides specialized instruction in the
principles and practice of cancer prevention and control. It focuses on
concepts, methods, issues, and applications related to this field.

**Target Audience**

Physicians, research fellows, scientists, and other health care
professionals who have an interest in cancer prevention and control.

**Course Modules**

Module 1: Introduction to the Cancer Problem

International Day: Cancer Prevention: An International Perspective

Module 2: Application of Cancer Prevention Methods

Module 3: Diet and Cancer Prevention

Module 4: Behavioral Science and Community Interventions

Module 5: Ethics, Law, and Policy in Cancer Prevention and Control

> Module 6: Epidemiology, Prevention, and Control of Site-Specific
> Tumors
>
> Special Lecture: Annual Advances in Cancer Prevention

Module 7: Health Disparities and Cancer Prevention in Diverse
Populations

Module 8: Occupational Cancer

Module 9: Disseminating Scientific Knowledge

**Educational Objectives**

The overall objective of the course is to provide specialized
instruction in the principles and practice of cancer prevention and
control. The course focuses on the concepts, methods, issues, and
applications related to this field. After attending this activity,
participants will be able to:

Adapt a broad-based perspective of these subjects, including resources,
data, methods, and theories. •Integrate lifetime learning skills,
including critical appraisal of the literature and bibliographic search
concepts and techniques.

**Module 1---Introduction to the Cancer Problem**

After attending this module, participants will be able to: recognize
cancer at different levels, from cell to organism; analyze
methodological foundations in reviewing scientific literature and
assessing cause; and promote an understanding of cancer databases and
illustrate how these are used in specific applications in cancer
prevention and control, including analysis and interpretation of data.

**International Day---Cancer Prevention: An International Perspective**

After attending this session, participants will be able to: discuss
public health issues (with a focus on cancer prevention and control) in
the countries represented by the international participants in the
course; and recognize the challenges in implementing cancer prevention
and control strategies in developing countries.

**Module 2---Application of Cancer Prevention Methods**

After attending this session, participants will be able to: describe and
illustrate the use of quantitative and qualitative methodologies in
cancer prevention and control; and design both randomized and
nonrandomized (observational) studies, including intervention trials,
screening studies, and general population surveys.

**Module 3---Diet and Cancer Prevention**

After attending this module, participants will be able to: translate the
role of diet and diet-related lifestyle factors (such as weight and
physical activity) in the etiology and prevention of cancer; and examine
the U.S. diet for the presence of food and nutrients pertinent to cancer
with special emphasis on both macro- and micronutrients on both animal
and human studies.

**Module 4---Behavioral Science and Community Interventions**

After attending this module, participants will be able to: analyze the
practical application of tobacco use to prevent and control cancer, and
identify health education strategies to bring about social and
behavioral changes in the community

**Module 5---Ethics, Law, and Policy in Cancer Prevention and Control**

After attending this module, participants will be able to: define the
relevant ethical and legal issues concerning the conduct of research and
practice in the field of cancer prevention and control.

**Module 6---Epidemiology, Prevention, and Control of Site-Specific
Tumors**

After attending this module, participants will be able to: interpret
state-of-the-art information on the descriptive epidemiology, etiology,
screening, and early detection of a majority of the major cancers; and
identify and adapt early detection methods in site-specific tumors.

**Special Lecture---Annual Advances in Cancer Prevention**

**Module 7---Health Disparities and Cancer Prevention in Diverse
Populations**

After attending this module, participants will be able to: compare and
apply cancer prevention and control strategies in several distinct
populations defined by race and/or ethnicity.

**Module 8---Occupational Cancer**

After attending this module, participants will be able to: examine the
role occupation plays in the etiology and prevention of various cancers.

**Module 9---Disseminating Scientific Knowledge**

After attending this module, participants will be able to: learn how
scientific knowledge is disseminated through the media.

**Continuing Medical Education (CME) Information**

**Accreditation Statement**

This activity has been planned and implemented in accordance with the
Essential Areas and policies of the Accreditation Council for Continuing
Medical Education through the joint sponsorship of The Johns Hopkins
University School of Medicine and The National Institutes of Health The
Johns Hopkins University School of Medicine is accredited by the ACCME
to provide continuing medical education for physicians.

**Credit Designation Statement**

The Johns Hopkins University School of Medicine designates this
educational activity for a maximum of [\[number of credits\]]{.mark}
*AMA PRA Category 1 Credit(s)*™. Physicians should only claim credit
commensurate with the extent of their participation in the activity.

# **Policy on Speaker and PROVIDER Disclosure**

It is the policy of The Johns Hopkins University School of Medicine that
the speaker and provider disclose real or apparent conflicts of interest
relating to the topics of this educational activity, and also disclose
discussions of unlabeled/unapproved uses of drugs or devices during
their presentation(s). The Johns Hopkins University School of Medicine
OCME has established policies in place that will identify and resolve
all conflicts of interest prior to this educational activity.

## Notice About Off-Label Use Presentations

The Johns Hopkins University School of Medicine/ Principles and Practice
of Cancer Prevention and Control may include presentations on drugs or
devices, or use of drugs or devices, that have not been approved by the
Food and Drug Administration (FDA) or have been approved by the FDA for
specific uses only. The FDA has stated that it is the responsibility of
the physician to determine the FDA clearance status of each drug or
device he or she wishes to use in clinical practice.

> The Johns Hopkins University School of Medicine is committed to the
> free exchange of medical education. Inclusion of any presentation in
> this program, including presentations on off-label uses, does not
> imply an endorsement by Johns Hopkins of the uses, products, or
> techniques presented.

**CONFIDENTIALITY DISCLAIMER FOR**

**CME CONFERENCE ATTENDEES**

I certify that I am attending a Johns Hopkins University School of
Medicine CME and National Institutes of Health activity for accredited
training and/or educational purposes.

I understand that while I am attending in this capacity, I may be
exposed to \"protected health information,\" as that term is defined and
used in NIH policy. Protected health information is information about a
person's health or treatment that identifies the person. The collection,
maintenance and use of such information at NIH are governed by the
Privacy Act of 1974, The Freedom of Information Act and the Public
Health Service Act.

I pledge and agree to use and disclose any of this protected health
information only for the training and/or educational purposes of my
visit and to keep the information confidential. And, except for the use
described above, medical and personal information may not be given to
anyone without the specific written permission of the subject
individual.

I understand that I may direct to the NIH Senior Official for Privacy
any questions I have about my obligations under this Confidentiality
Pledge or under any of the Hopkins policies and procedures and
applicable laws and regulations related to confidentiality. The contact
information is: Office of the Senior Official for Privacy, telephone:
(301) 451-3426,

e-mail: <privacy@mail.nih.gov>.

**"The Office of Continuing Medical Education at The Johns Hopkins
University School of Medicine, as provider of this activity, has relayed
information with the CME attendees/participants and certify that the
visitor is attending for training, education and/or observation purposes
only."**

**Module 1: Introduction to the Cancer Problem**

July 7 through 10

Educational Objective: After attending this module, participants will be
able to: recognize cancer at different levels, from cell to organism;
analyze methodological foundations in reviewing scientific literature
and assessing cause; and promote an understanding of cancer databases
and illustrate how these are used in specific applications in cancer
prevention and control, including analysis and interpretation of data.

**[Monday, July 7]{.underline}**

8:30 a.m.-9:00 a.m. Welcome Jonathan Wiest, PhD

9:00 a.m.-9:30 a.m. Opening Remarks Peter Greenwald, MD, DrPH

9:30 a.m.-10:30 a.m. **Coffee Break, Photos**

10:30 a.m.-12:00 noon Cancer Prevention From a Biologist's Jackie
Lavigne, PhD, MPH

Perspective

1:00 p.m.-1:45 p.m. Overview on Cancer Prevention from the Veronica
Chollette, MS, RN

Behavioral Scientist's Perspective

1:45 p.m.-2:30 p.m. NCI's Role in Cancer Control Robert Croyle, PhD

**[Tuesday, July 8]{.underline}**

8:30 a.m.-10:00 a.m. Randomized Trials Anthony Alberg, PhD, MPH

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Observational Studies Anthony Alberg, PhD, MPH

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Consideration for Analysis and Interpretation
Michael Goodman, MD, MPH

of Epidemiologic Data

**[Wednesday, July 9]{.underline}**

8:30 a.m.-10:00 a.m. What Is the Current Evidence for Progress Bruce
Trock, PhD, MPH

Against Cancer?

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon National and International Trends in Cancer Bruce
Trock, PhD, MPH

Incidence, Mortality, and Survival

12:00 noon.-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. The Use of Geographic Analysis Methods David
Stinchcomb, MA, MS

in Cancer Control

**[Thursday, July 10]{.underline}**

8:30 a.m.-10:00 a.m. Issues in Interpreting Cancer Statistics Bruce
Trock, PhD, MPH

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Prevention vs. Treatment and the Next Bruce Trock,
PhD, MPH

Decade of Progress

12:00 noon - 1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Accessing and Analyzing Health Survey Data Richard
P. Moser, PhD

**International Day**

**Cancer Prevention: An International Perspective**

July 11

Educational Objective: After attending this session, participants will
be able to: discuss public health issues (with a focus on cancer
prevention and control) in the countries represented by the
international participants in the course; and recognize the challenges
in implementing cancer prevention and control strategies in developing
countries.

**[Friday, July 11]{.underline}**

8:30 a.m.-10:15 a.m. **Asia**

8:30 a.m.-8:40 a.m. China

8:40 a.m. -8:50 a.m. India

8:50 a.m.-9:00 a.m. Taiwan

9:00 a.m.-9:10 a.m. Vietnam

9:10 a.m.-9:20 a.m. Sri Lanka

**Middle East**

9:20 a.m.-9:30 a.m. Yemen

9:30 a.m. - 9:40 a.m. Iraq

9:40 a.m. -- 9:50 a.m. Israel

9:50 a.m. -- 10:00 a.m. Syria

**Questions**

10:00 a.m. - 10:15 a.m.

10:15 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon **Europe**

10:30 a.m.-10:40 a.m. Bulgaria

10:40 a.m.-10:50 a.m. Georgia

10:50 a.m.-11:00 a.m. Republic of Ireland

11:00 a.m.-11:10 a.m. Northern Ireland

11:10 a.m.-11:20 a.m. Montenegro

11:20 a.m.-11:30 a.m Russia

11:30 a.m.-11:40 a.m. Albania

11:40 a.m- 11:50 a.m United Kingdom

**Questions**

11:50-12:00

12:00 noon -1:00 p.m. **Lunch**

1:00 p.m.-3:20 p.m. **Africa**

1:00 p.m.-1:10 p.m. Angola

1:10 p.m.-1:20 p.m. Kenya

1:20 p.m.-1:30 p.m. Mozambique 1:30 p.m.-1:40 p.m. Nigeria

1:40 p.m.-1:50 p.m. Tanzania

1:50 p.m.-2:00 p.m. Zambia

> **Central & South America**
>
> 2:00 p.m.-2:10 p.m. El Salvador
>
> 2:10 p.m.-2:20 p.m. Nicaragua
>
> 2:20 p.m.-2:30 p.m. Argentina
>
> 2:30 p.m.-2:40 p.m. Brazil
>
> 2:40 p.m.-2:50 p.m. Chile
>
> 2:50 p.m.-3:00 p.m. Peru
>
> **Questions**
>
> 3:00 p.m.-3:20 p.m.

**Module 2: Application of Cancer Prevention Methods**

July 14

Educational Objective: After attending this session, participants will
be able to: describe and illustrate the use of quantitative and
qualitative methodologies in cancer prevention and control; and design
both randomized and nonrandomized (observational) studies, including
intervention trials, screening studies, and general population surveys.

**[Monday, July 14]{.underline}**

8:30 a.m.-10:00 a.m. Randomized Trials of Screening Pamela Marcus, PhD,
MS

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Transdisciplinary Studies of Energy Balance David
Berrigan, PhD, MPH

and Cancer

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Biomarkers in Cancer Prevention Nancy Potischman,
PhD

**Module 3: Diet and Cancer Prevention**

July 15 through 16

Educational Objective: After attending this module, participants will be
able to: translate the role of diet and diet-related lifestyle factors
(such as weight and physical activity) in the etiology and prevention of
cancer; and examine the U.S. diet for the presence of food and nutrients
pertinent to cancer with special emphasis on both macro- and
micronutrients on both animal and human studies.

**[Tuesday, July 15]{.underline}**

8:30 a.m.-10:00 a.m. Diet in Cancer at a Crossroads: Do We Arthur
Schatzkin, MD, DrPH

Know What To Believe---or Even Believe

What We Know?

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Energy Balance, Anthropometrics, and Rachel
Ballard-Barbash, MD, MPH

Cancer

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Dietary Assessment Methods in Cancer Amy F. Subar,
PhD, MPH, RD

Epidemiology

**[Wednesday, July 16]{.underline}**

8:30 a.m.-10:00 a.m. Preclinical and Clinical Evidence Linking John
Milner, PhD

Functional Foods With Cancer Prevention

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon The "Omics" of Nutrition and Bioactive Cindy
Davis, PhD

Food Components in Cancer Prevention

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Physical Activity and Dietary Behavior Audie
Atienza, PhD

for Cancer Prevention

**Module 4: Behavioral Science and Community Interventions**

July 17 through 21

Educational Objective: After attending this module, participants will be
able to: analyze the practical application of tobacco use to prevent and
control cancer, and identify health education strategies to bring about
social and behavioral changes in the community

**[Thursday, July 17]{.underline}**

8:30 a.m.-10:00 a.m. Harnessing the Power of an Intelligent Bradford
Hesse, PhD

> Health Environment in Cancer Control

and Prevention

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon An Overview of Key Issues in Tobacco Control Erik
Augustson, PhD, MPH

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Tobacco Use and Addiction Neal Grunberg, PhD

**[Friday, July 18]{.underline}**

8:30 a.m.-10:00 a.m. Obesity, Metabolism and Cancer Prevention Stephen
Hursting, PhD, MPH, RD

**(Lecture is part of Module 3)**

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Pitfalls to Avoid in Questionnaire Design Gordon
Willis, PhD

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. The Role of Literacy and Health Literacy Terry
Davis, PhD

in Cancer Prevention and Outcomes

**Module 5: Ethics, Law, and Policy in Cancer Prevention and Control**

July 21

Educational Objective: After attending this module, participants will be
able to: define the relevant ethical and legal issues concerning the
conduct of research and practice in the field of cancer prevention and
control.

**[Monday, July 21]{.underline}**

8:30 a.m.-10:00 a.m. Health Disparities in Cancer Control Shobha
Srinivasan, PhD

**(Lecture is part of Module 7- Heath Disparities)**

10:30 a.m.-12:00 noon The Ethics of HPV Vaccine Dissemination Patti
Gravitt, MS, PhD

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Law and Policy in Cancer Prevention Kerri McGowan
Lowrey, JD, MPH

and Control

**Note**: Final lecture of this module, Research Ethics, held on July
30th.

**Module 6: Epidemiology, Prevention, and Control of Site-Specific
Tumors**

July 22 through 30

Educational Objective: After attending this module, participants will be
able to: interpret state-of-the-art information on the descriptive
epidemiology, etiology, screening, and early detection of a majority of
the major cancers; and identify and adapt early detection methods in
site-specific tumors.

**[Tuesday, July 22]{.underline}**

8:30 a.m.-10:00 a.m. Approaches for Clinical Cancer Prevention Mark
Greene, MD

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Lung and Aerodigestive Tract Cancers Eva Szabo, MD

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Esophageal Cancer Philip Taylor, MD, ScD

**[Wednesday, July 23]{.underline}**

8:30 a.m.-10:00 a.m. Prostate Cancer Howard Parnes, MD

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Skin Cancer Alan Geller, RN, MPH

12:00 noon-1:00 p.m. **Lunch**

12:30 NIH BUS TOUR (optional)

3:00 p.m.- 4:00 p.m. **Annual Advances in Cancer Prevention Lecture**

Dr. Patricia Ganz

Cancer Survivors: Charting an Agenda for Research, Treatment and Quality
of Care

Presented at Lister Hill Auditorium, NIH Main Campus, Building 38A

**[Thursday, July 24]{.underline}**

8:30 a.m.-10:00 a.m. Endometrial Cancer James Lacey, Jr., PhD, MPH

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Cervical Cancer Philip Castle. PhD, MPH

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Breast Cancer Victor Vogel, MD

**[Friday, July 25]{.underline}**

8:30 a.m.-10:00 a.m. Ovarian Cancer Kala Visvanathan, MBBS, FRACP,

MHS

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Putting Cancer Control Into Practice Stephen
Taplin, MD, MPH

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m. Afternoon Social Activity in Washington, DC

**[Monday, July 28]{.underline}**

8:30 a.m.-10:00 a.m. Bladder Cancer Jonine Figueroa, PhD, MPH

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Colon Cancer Amanda J. Cross, PhD

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Interpreting Scientific Evidence for Douglas Weed,
MD, PhD, MPH

Cancer Prevention

**[Tuesday, July 29]{.underline}**

8:30 a.m.-10:00 a.m. Liver Cancer John Groopman, PhD

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Infections as a Cause of Sam Mbulaiteye, MD

Non-Hodgkins Lymphoma and Eric Engels, MD, MPH

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Radiation and Cancer Prevention Alice Sigurdson, PhD

**[Wednesday, July 30]{.underline}**

8:30 a.m.-10:00 a.m. Multiple Myeloma; A Rare Cancer with Dalsu Baris,
MD, PhD

Health Disparities

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Complementary and Alternative Medicine Jeffrey
White, MD

in Cancer

12:00 noon-1:00 p.m. **Lunch**

1:00 p.m.-2:30 p.m. Research Ethics David Wendler, PhD

**(Lecture is part of Module 5- Ethics)**

**Module 7: Health Disparities and Cancer Prevention**

**in Diverse Populations**

July 31

Educational Objective: After attending this module, participants will be
able to: compare and apply cancer prevention and control strategies in
several distinct populations defined by race and/or ethnicity.

**[Thursday, July 31]{.underline}**

8:30 a.m.-10:00 a.m. Quality of Care Issues in Survivors Ashley
Wilder-Smith, PhD, MPH

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon Hispanic Populations Olivia Carter-Pokras, MHS,
PhD

12:00 noon-1:00 p.m. **Lunch**

**Note**: Third lecture of this module, Health Disparities in Cancer
Control, held on July 21st.

**Module 8: Occupational Cancer**

July 31

Educational Objective After attending this module, participants will be
able to: examine the role occupation plays in the etiology and
prevention of various cancers.

**[Thursday, July 31]{.underline}**

1:00 p.m.-2:30 p.m. Occupational Cancer Laura Beane-Freeman, PhD, MPH

**Module 9: Disseminating Scientific Knowledge**

August 1

Educational Objective: After attending this module, participants will be
able to: learn how scientific knowledge is disseminated through the
media.

**[Friday, August 1]{.underline}**

8:30 a.m.-10:00 a.m. Cancer Control PLANET Cynthia A. Vinson, MPA

10:00 a.m.-10:30 a.m. **Break**

10:30 a.m.-12:00 noon The History of the Irish Smoking Ban Fenton
Howell, FFPHMI, FRCPI

**Faculty**

**Alberg, Anthony, PhD, MPH** --- *Module 1: Introduction to the Cancer
Problem*

> Associate Director of Cancer Prevention and Control, Blatt Ness
> Endowed Chair in Oncology, Hollings Cancer Center, Medical University
> of South Carolina, 86 Jonathan Lucas Street, P.O. Box 250955,
> Charleston, SC 29425; 843-792-9588; <alberg@musc.edu>

**Atienza, Audie, PhD** --- *Module 3: Diet and Cancer*

> Program Director, Behavioral Research Program, Division of Cancer
> Control and Population Sciences,
>
> NCI, NIH, Executive Plaza North, Room 4082, 6130 Executive Boulevard,
> Bethesda, MD 20892-7335; 301-402-8426;
> [atienza2@mail.nih.gov](mailto:alberg@musc.edu)

**Augustson, Erik, PhD, MPH** --- *Module 4: Behavioral Science and
Community Interventions*

> Behavioral Scientist/Psychologist, Tobacco Control Research Branch,
> Division of Cancer Control and Population Sciences,
> NCI/SAIC-Frederick, NIH, Executive Plaza North, Room 4039B, 6130
> Executive Boulevard, Bethesda, MD 20892-7337; 301-435-7610;
> augustse@mail.nih.gov

**Ballard-Barbash, Rachel, MD, MPH** --- *Module 3: Diet and Cancer*

> Associate Director, Applied Research Program, Division of Cancer
> Control and Population Sciences,
>
> NCI, NIH, Executive Plaza North, Room 4005, MSC 7344, 6130 Executive
> Boulevard, Bethesda, MD 20892-7344; barbashr@mail.nih.gov

**Baris, Dalsu, MD, PhD** --- *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Occupational and Environmental Epidemiology Branch**,** Occupational
> and Environmental Epidemiology Branch, NCI, NIH, Executive Plaza South
> Room 8122**,** 6120 Executive Boulevard**,** Rockville, MD 20892;
> 301-435-4707; <barisd@mail.nih.gov>

**Beane-Freeman, Laura, PhD, MPH** --- *Module 8: Occupational Cancer*

> Research Fellow, Occupational and Environmental Epidemiology Branch,
> Division of Cancer Epidemiology and Genetics, NCI, NIH, Executive
> Plaza South, Room 8007**,** 6120 Executive Boulevard**,** Rockville,
> MD 20892; 301-451-8793; freemala@mail.nih.gov

**Berrigan, David, PhD, MPH --** *Module 2: Application of Cancer
Prevention Methods*

Biologist, Applied Research Program, Division of Cancer Control and
Population Sciences, NCI, NIH, Executive Plaza North, Room 4095B, 6130
Executive Blvd., Bethesda, MD, 20892; 301-451-4301;
berrigad@mail.nih.gov

**Carter-Pokras, Olivia, MHS, PhD** --- *Module 7: Health Disparities
and Cancer Prevention in Diverse Populations*

Associate Professor, Department of Epidemiology and Preventive Medicine,
University of Maryland, College Park, School of Public Health, 1240D HHP
Bldg., College Park, MD 2074; 310-405-8037; opokras@umd.edu

**Castle, Philip, PhD, MPH** --- *Module 6: Epidemiology, Prevention,
and Control of Site-Specific Tumors* Investigator, Hormonal and
Reproductive Epidemiology Branch, Division of Cancer Epidemiology and
Genetics, NCI, NIH, Executive Plaza South, Room 7074, 6120 Executive
Boulevard, Bethesda, MD 20892-7234; 301-435-3976; castlep@mail.nih.gov

**Chollette, Veronica, MS, RN** --- *Module 1: Introduction to the
Cancer Problem,* Program Director, Applied Cancer Screening Research
Branch, DCCPS, NCI, NIH, Executive Plaza North, Room 4100, 6130
Executive Boulevard, Bethesda, MD 20892-7234, <cholletv@mail.nih.gov>

[]{.mark}

**Cross, Amanda, PhD** --- *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Investigator, Nutritional Epidemiology Branch, Division of Cancer
> Epidemiology and Genetics, NCI, NIH, Executive Plaza South, Room 3050,
> 6120 Executive Boulevard, Bethesda, MD 20892-7232; 301-496-4378;
> ac390s@mail.nih.gov

**Croyle, Robert, PhD** --- *Module 1: Introduction to the Cancer
Problem*

> Director, Division of Cancer Control and Population Sciences, NCI,
> NIH, Executive Plaza North, Room 6138, 6130 Executive Boulevard,
> Rockville, MD 20852-7338; 301-594-6776; <croyler@mail.nih.gov>

**Davis, Cindy, PhD** --- *Module 3: Diet and Cancer*

> Program Director, Nutritional Sciences Research Group, Division of
> Cancer Prevention, Department of Health and Human Services, NCI, NIH,
> Executive Plaza North, Suite 3159, 6130 Executive Boulevard, Bethesda,
> MD 20892-7328; 301-594-9692; <davisci@mail.nih.gov>

**Davis, Terry, PhD** --- *Module 4: Behavioral Science and Community
Interventions*

> Professor, Medicine and Pediatrics, Feist-Weiller Cancer Center,
> Louisiana State University Health Sciences Center, 1501 Kings Highway,
> Shreveport, LA 71130-3932l; 318-675-5813; TDavis1@lsuhsc.edu

**Engels, Eric A., MD, MPH** --- *Module 6: Epidemiology, Prevention,
and Control of Site-Specific Tumors*

> Viral Epidemiology Branch, Division of Cancer Epidemiology and
> Genetics, NCI, NIH, Executive Plaza South Room 7076, 6120 Executive
> Boulevard, Rockville, MD 20892; 301-402-3654;
> <engels@exchange.nih.gov>

**Figueroa, Jonine, PhD, MPH** --- *Module 6: Epidemiology, Prevention,
and Control of Site-Specific Tumors*

> Hormonal and Reproductive Epidemiology Branch, Division of Cancer
> Epidemiology and Genetics, NCI, NIH, Executive Plaza South Room 5006,
> 6120 Executive Boulevard, Rockville, MD 20892; 301-496-8115;
> figueroaj@mail.nih.gov

**Geller, Alan, RN, MPH** --- *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Associate Professor, Departments of Dermatology and Epidemiology,
> Boston University Medical Center, 720 Harrison Avenue DOB801A, Boston,
> MA 02118; 617-638-7126; ageller@bu.edu

**Goodman, Michael, MD, MPH** --- *Module 1: Introduction to the Cancer
Problem*

> Assistant Professor, Department of Epidemiology, Emory University
> School of Public Health, 1518 Clifton Rd., NE, Atlanta, GA 30322;
> 404-727-8737; <mgoodm2@sph.emory.edu>

**Gravitt, Patti E. ---***Module 5: Ethics, Law, and Policy in Cancer
Prevention and Control*

> Associate Professor of Epidemiology, Johns Hopkins Bloomberg School of
> Public Health, 615 N. Wolfe St. , Room E6148, Baltimore, MD 21205;
> 443-287-6179; pgravitt@jhsph.edu

**Greene, Mark, MD** --- *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Chief, Clinical Genetics Branch, Division of Cancer Epidemiology and
> Genetics, NCI, NIH, Executive Plaza South, Room 7022, 6120 Executive
> Boulevard, Bethesda, MD 20892; 301-594-7641; greenem@mail.nih.gov

**Greenwald, Peter, MD, DrPH-** *Module 1: Introduction to the Cancer
Problem*

> Director, Division of Cancer Prevention, NCI, NIH, Executive Plaza
> North, Room 2040, 6130 Executive Boulevard, Bethesda, MD 20892;
> 301-496-6616, greenwap@mail.nih.gov

**Groopman, John, PhD** --- *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Professor and Chair, Department of Environmental Health Sciences;
> Associate Director, Cancer Prevention and Control, Sidney Kimmel
> Comprehensive Cancer Center, Johns Hopkins Bloomberg School of Public
> Health,

615 N. Wolfe Street, Room E7527, Baltimore, MD 21205; 410-955-3720;
jgroopma@jhsph.edu

**Grunberg, Neal, PhD ---** *Module 4: Behavioral Science and Community
Interventions*

> Professor of Medical and Clinical Psychology, Professor of
> Neuroscience, Department of Medical and Clinical Psychology, Uniformed
> Services University of the Health Sciences, 4301 Jones Bridge Road,
> Bethesda, MD 20814; 301-295-3270; grunberg@usuhs.mil

**Hesse, Bradford, PhD** --- *Module 4: Behavioral Science and Community
Interventions*

> Acting Chief, Health Communications and Informatics Research Branch,
> Behavioral Research Program, Division of Cancer Control and Population
> Sciences, NCI, NIH, Executive Plaza North, Room 4068, MSC 7365, 6130
> Executive Boulevard, Bethesda, MD 20892-7365; 301-594-9904;
> hesseb@mail.nih.gov

**Howell, Fenton, -** *Module 9: Disseminating Scientific Knowledge*

> Population Health Directorate, Health Service Executive, Railway
> Street, Navan, Co. Meath, Ireland; fenton.howell@hse.ie

**Hursting, Stephen, PhD, MPH, RD** --- *Module 3: Diet and Cancer*

Professor and McKean-Love Chair of Molecular, Cellular, and Nutritional
Sciences, University of Texas at Austin, and the MD Anderson Cancer
Center, Gearing Hall 117, Austin, TX 78712; 512-471-2809;
shursting@mail.utexas.edu

**Lacey, James, PhD --** *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Investigator, Hormonal and Reproductive Epidemiology Brach, Division
> of Cancer Epidemiology and Genetics, NCI, NIH, Executive Plaza South,
> Room 5030, 6120 Executive Plaza, Bethesda, MD 20892; 301-402-0916;
> <jimlacey@nih.gov>

**Lavigne, Jackie, PhD, MPH** --- *Module 1: Introduction to the Cancer
Problem*

Chief, Office of Education, Division of Cancer Epidemiology and
Genetics, NCI, NIH, Executive Plaza South, Room T-41, 6120 Executive
Boulevard, Bethesda, MD 20892-7361; 301-496-8640; lavignej@mail.nih.gov

**Marcus, Pamela, PhD, MS** --- *Module 2: Application of Cancer
Prevention Methods*

> Epidemiologist, Biometry Research Group, Division of Cancer
> Prevention, NCI, NIH, Executive Plaza North, Room 3160, MSC 7328, 6130
> Executive Boulevard, Bethesda, MD 20892-7354; 301-496-7468;
> pm145q@nih.gov

**Mbulaiteye, Sam, MD** --- *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Infections and Immunoepidemiology Branch, Division of Cancer
> Epidemiology and Genetics, NCI, NIH, EPS/7080, 6120 Executive Blvd,
> Bethesda, MD 20892; 301-594-7825; mbulaits@mail.nih.gov

**McGowan Lowrey, Kerri, JD, MPH---***Module 5: Ethics, Law, and Policy
in Cancer Prevention and Control*

> Center Manager and Senior Legislative/Policy Analyst, Center for
> Health Policy and Legislative Analysis, The Maya Tech Corporation,
> 1100 Wayne Avenue, Suite 900, Silver Spring, MD 20910; 301-587-1600,
> ext. 2204; [klowrey@mayatech.com](mailto:klowrer@mayatech.com)

**Milner, John, PhD** --- *Module 3: Diet and Cancer*

> Chief, Nutritional Sciences Research Group, Division of Cancer
> Prevention, NCI, NIH, Executive Plaza North, Room 3160, MSC 7328, 6130
> Executive Boulevard, Bethesda, MD 20892-7328; 301-496-8573;
> <jm524n@nih.gov>

**Moser, Richard, PhD** --- *Module 1: Introduction to the Cancer
Problem*

Research Psychologist, Behavioral Research Program, Division of Cancer
Control and Population Sciences, NCI, NIH, Executive Plaza North, Room
4052, 6130 Executive Boulevard, Bethesda, MD 20892-7328; 301-496-0273;
moserr@mail.nih.gov

**Parnes, Howard --** *Module 6: Epidemiology, Prevention, and Control
of Site-Specific Tumors*

> Chief, Prostate and Urologic Cancer Research Group, Division of Cancer
> Prevention, NCI, NIH, Executive Plaza North, Room 2100, MSC 7333, 6130
> Executive Boulevard, Bethesda, MD 20892-7025; 301-496-2522;
> <parnesh@mail.nih.gov>

**Potischman, Nancy, PhD** --- *Module 2: Application of Cancer
Prevention Methods*

> Biomarker Surveillance Epidemiologist, Office of the Associate
> Director, Applied Research Program, Division of Cancer Control and
> Population Sciences, NCI, NIH, Executive Plaza North, Room 4008, 6130
> Executive Boulevard, Bethesda, MD 20892-7344; 301-594-6573;
> potischn@mail.nih.gov

**Schatzkin, Arthur, MD, DrPH** --- *Module 3: Diet and Cancer*

> Chief, Nutritional Epidemiology Branch, Division of Cancer
> Epidemiology and Genetics, NCI, NIH, Executive Plaza South, Room 3040,
> 6120 Executive Boulevard, Bethesda, MD 20892; 301-594-2931;
> <schatzka@mail.nih.gov>

**Sigurdson, Alice, PhD --** *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Radiation and Epidemiology Branch, Division of Cancer Epidemiology and
> Genetics, NCI, NIH, Executive Plaza South, Room 3041, 6120 Executive
> Blvd, Bethesda, MD 20892; 301-594-791; <sigurdsa@mail.nih.gov>

**Smith, Ashley Wilder, PhD, MPH** --- *Module 7: Health Disparities and
Cancer Prevention in Diverse Populations*

> Behavioral Scientist, Outcomes Research Branch, Applied Research
> Program, Division of Cancer Control and Population Sciences, NCI, NIH,
> Executive Plaza North, Room 4090, 6130 Executive Boulevard, Bethesda,
> MD 20892-7344; 301-451-1843; [smithas@mail.nih.gov]{.underline}

**Srinivasan, Shobah, PhD** --- *Module 7: Health Disparities and Cancer
Prevention in Diverse Populations*

> Health Disparities Research Coordinator, Division of Cancer Control
> and Population Sciences, NCI, NIH, Executive Plaza North, Room 6126,
> 6130 Executive Boulevard, Bethesda, MD 20892-7338; 301-435-6614;
> [Sriniva2@mail.nih.gov]{.underline}

**Stinchcomb, David, MA, MS --** *Module 1: Introduction to the Cancer
Problem*

> Chief, Cancer Statistics Branch, Division of Cancer Control and
> Population Sciences, NCI, NIH, 6116 Executive Plaza Room 5037,
> Bethesda, MD 20892; 301-594-7251; stinchcd@mail.nih.gov

**Subar, Amy, PhD, MPH, RD** --- *Module 3: Diet and Cancer*

> Applied Research Program, Division of Cancer Control and Population
> Sciences, NCI, NIH, Executive Plaza North, Room 4005, 6130 Executive
> Boulevard, Bethesda, MD 20892; 301-594-0831;
> [subara@mail.nih.gov](mailto:schatzka@mail.nih.gov)

**Szabo, Eva, MD** --- *Module 6: Epidemiology, Prevention, and Control
of Site-Specific Tumors*

> Chief, Lung and Upper Aerodigestive Cancer Research Group, Division of
> Cancer Prevention, NCI, NIH, Executive Plaza North, Room 2103, MSC
> 7341, 6130 Executive Boulevard, Bethesda, MD 20892-7341;
>
> 301-435-1595; es99v@nih.gov

**Taplin, Stephen, MD, MPH** --- *Module 6: Epidemiology, Prevention,
and Control of Site-Specific Tumors*

> Senior Scientist, Applied Research Program, Division of Cancer Control
> and Population Sciences, NCI, NIH, Executive Plaza North, Room 4005,
> MSC 7344, 6130 Executive Boulevard, Bethesda, MD 20892-7344;
>
> 301-402-1483; taplins@mail.nih.gov

**Taylor, Philip, MD, ScD** --- *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Senior Investigator, Genetic Epidemiology Branch, Division of Cancer
> Epidemiology and Genetics, NCI, NIH, Executive Plaza South, 6120
> Executive Boulevard, Room 7122, Bethesda, MD 20892; 301-594-2932;
> <ptaylor@mail.nih.gov>

**Trock, Bruce, PhD, MPH---***Module 1: Introduction to the Cancer
Problem*

> Associate Professor of Urology, Associate Professor of Epidemiology,
> Associate Professor of Oncology, Department of Urology and
> Epidemiology, Johns Hopkins Medical Institution, 600 N. Wolfe Street,
> Jefferson Street Building, Room 149, Baltimore, MD 21287-8915;
> 410-502-2773; <btrock@jhmi.edu>

**Visvanathan, Kala, MBBS, FRACP, MHS** --- *Module 6: Epidemiology,
Prevention, and Control of Site-Specific Tumors*

> Assistant Professor in Oncology, Departments of Epidemiology and
> Oncology, John Hopkins Bloomberg School of Public Health, 615 N Wolfe
> St, E 6142, Baltimore MD 21205; 410-614-1112; kvisvana@jhsph.edu

**Vogel, Victor, MD** --- *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Professor of Medicine and Epidemiology, Division of
> Hematology/Oncology, University of Pittsburgh School of Medicine, UPMC
> Cancer Center Magee-Women's Hospital, 300 Halket Street, Room 3524,
> Pittsburgh, PA 1521; 412-641-4530; vvogel@mail.magee.edu

**Weed, Douglas, MD, MPH, PhD** ---*Module 6: Epidemiology, Prevention,
and Control of Site-Specific Tumors*

> 3706 Farragut Avenue, Kensington, MD 20895; douglaslweed@aol.com

**Wendler, David S., PhD** ---*Module 5: Ethics*

> Research Fellow, Clinical Bioethics Department, Building 10 --
> Magnuson CC, 1C118, 10 Center Drive, Bethesda, MD 20892-1156;
> 301-435-8726; dwendler@mail.cc.nih.gov

**White, Jeffrey D., MD** --- *Module 6: Epidemiology, Prevention, and
Control of Site-Specific Tumors*

> Director, Office of Cancer Complementary and Alternative Medicine,
> NCI, NIH, 6116 Executive Boulevard, Bldg. 6116, Rm. 609, Bethesda, MD
> 20892-8339; 301-435-7980; jeffreyw@mail.nih.gov

**Wiest, Jonathan, PhD** ---*Module 1: Introduction to the Cancer
Problem*

> Acting Director, Cancer Prevention Fellowship Program, NCI, NIH,
> Executive Plaza South, Room T-41, 6120 Executive Boulevard, Bethesda,
> MD 20892-7361; 301-496-8640; wiestj@mail.nih.gov

**Willis, Gordon, PhD --** *Module 4: Behavioral Science and Community
Interventions*

> Cognitive Psychologist, Applied Research Program, Division of Cancer
> Control and Population Sciences, NCI, NIH, Executive Plaza North, Room
> 4006, 6130 Executive Blvd, Bethesda, MD, 20892; 301-594-6652;
> <willisg@mail.nih.gov>

**Vinson, Cynthia A., MPA-** *Module 9: Disseminating Scientific
Knowledge*

> Dissemination and Diffusion Coordinator, Division of Cancer Control
> and Population Sciences, NCI, NIH, Office of the Director, DCCPS,
> Executive Plaza South, Rm. 7060, 6120 Executive Boulevard, Bethesdsa,
> MD 20892; 301-594-5906; <cvinson@mail.nih.gov>